The trademark neopharma was filed by NEOPHARMA a.s., a corporation established under the laws of the Czech Republic (the "Applicant"). The application was published for oppositions on May 5, 2021, and received undefined oppositions.
There are undefined Oppositions claimed against trademark.
The first opposition filed on August 3, 2021 by NEOPHARMED GENTILI S.p.A. on (a) Art. 8(4), (b) Likelihood of confusion. the opponent was represented by CON LOR S.P.A. and its proceedings were handled in English The second opposition filed on July 19, 2021 by NEOPHARM OOD on Likelihood of confusion. the opponent was represented by Darakev, Rumen Dontchev and its proceedings were handled in English
The application was filed in Czech, and Czech was also language of all opposition proceedings (English was selected as the second language).
The Opposition with reference B 003151023 was partially refused EUTMA/IR according to Article 8(1)(b) EUTMR with decision issued on January 22, 2023 by the EUIPO.